Delivery Order SPE2DX22D0049-SPE2D825FA9GN
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $10,750.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued with no set-aside designation, represents a competitively awarded contract under the Defense Logistics Agency's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order valued at $16,605.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office facility in Conshohocken, Pennsylvania. The contract was executed as a child order under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $6,146.83 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under a larger indefinite delivery vehicle and requires performance at the awardee's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,441.99 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 27, 2025, with a completion date of June 30, 2025. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents a task order under a larger Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $10,065.24 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $46,349.46 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the federal procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical supply...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $870,087.71 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $21,103.45 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 5, 2025. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, was awarded on a competitive basis with no set-aside designation. The contract is scheduled for completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $138,601.43 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued without set-aside provisions, represents a competitively awarded transaction under which AmerisourceBergen will supply pharmaceutical products and medical supplies to support federal medical procurement needs. The contract...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FA9GNDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $14,013.99 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides a flexible contracting mechanism enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The underlying IDC demonstrates AmerisourceBergen's capability to meet federal procurement requirements through open competition and positions the company as a strategic pharmaceutical supplier within the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 7/28/25 |